Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: Recent developments

European Heart Journal

Volumn 36, Issue 45, 2015, Pages 3155-3164c

  Berry, Colin ^a,b   Corcoran, David ^a,b   Hennigan, Barry ^a   Watkins, Stuart ^a   Layland, Jamie ^c   Oldroyd, Keith G ^a  

^a GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Fractional flow reserve Stable angina Myocardial infarction Medical therapy Coronary revascularization

Indexed keywords

ADENOSINE; CAFFEINE; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; CALCULATION; CARDIAC IMAGING; CARDIOVASCULAR FUNCTION; CENTRAL VENOUS PRESSURE; CLINICAL ASSESSMENT; CLINICAL CLASSIFICATION; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; COMPUTATIONAL FLUID DYNAMICS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; CORONARY VASCULAR RESISTANCE; DIAGNOSTIC TEST; FRACTIONAL FLOW RESERVE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART RIGHT ATRIUM PRESSURE; HUMAN; HYPEREMIA; INTRAVASCULAR ULTRASOUND; MANAGED CARE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; REVIEW; SEX ALLOCATION; VASCULAR RESISTANCE; VASODILATATION; AGE; BLOOD PRESSURE MEASUREMENT; CORONARY DISEASE; CORONARY STENOSIS; FORECASTING; INTRAVENOUS DRUG ADMINISTRATION; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE;

ACUTE CORONARY SYNDROME; ADENOSINE; AGE FACTORS; BLOOD PRESSURE DETERMINATION; CARDIAC IMAGING TECHNIQUES; CENTRAL VENOUS PRESSURE; CORONARY DISEASE; CORONARY STENOSIS; FORECASTING; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; INFUSIONS, INTRAVENOUS; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 84983119868     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv206     Document Type: Review

References (95)

1. Pijls NH, De Bruyne B. Coronary Pressure. 2nd Ed. The Netherlands: Kluwer Academic Publishers, 2000.
2. US National Library of Medicine. Fractional flow reserve. http://www.ncbi.nlm. nih.gov/pubmed/?term=fractional+flow+reserve (15 March 2015).
3. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34: 2949-3003.
4. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A; Authors/Task Force members. 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-2619.
5. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG. Standards for reporting of diagnostic accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003;138:W1-W12.
6. Schulz KF, Altman DG, Moher D;CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340: c332.
7. Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European Cardiovascular Disease Statistics 2012. Brussels/Sophia Anti-polis: European Heart Network/European Society of Cardiology, 2012.
8. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statis-tics-2014 update: a report from the American Heart Association. Circulation 2014;129:e28-e292.
9. World Health Organisation. Cardiovascular disease. http://www.who.int/cardiovascular-diseases/en/(15 March 2015).
10. Toth G, Hamilos M, Pyxaras S, Mangiacapra F, Nelis O, De Vroey F, Di Serafino L, Muller O, Van Mieghem C, Wyffels E, Heyndrickx GR, Bartunek J, Vanderheyden M, Barbato E, Wijns W, De Bruyne B. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J 2014;35:2831-2838.
11. Spaan JA, Piek JJ, Hoffman JI, Siebes M. Physiological basis of clinically used coronary hemodynamic indices. Circulation 2006;113:446-455.
12. van de Hoef TP, Meuwissen M, Escaned J, Davies JE, Siebes M, Spaan JA, Piek JJ. Fractional flow reserve as a surrogate for inducible myocardial ischaemia. Nat Rev Cardiol 2013;10:439-452.
13. van de Hoef TP, Bax M, Damman P, Delewi R, Hassell ME, Piek MA, Chamuleau SA, Voskuil M, van Eck-Smit BL, Verberne HJ, Henriques JP, Koch KT, de Winter RJ, Tijssen JG, Piek JJ, Meuwissen M. Impaired coronary autoregulation is associated with long-term fatal events in patients with stable coronary artery disease. Circ Cardiovasc Interv 2013;6:329-335.
14. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-1367.
15. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J, Koolen JJ, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-1708.
16. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001;103:2928-2934.
17. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-224.
18. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367:991-1001.
19. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E, Jüni P; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014; 371:1208-1217.
20. Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv 2014;7:581-591.
21. Echavarŕia-Pinto M, Gonzalo N, Ibanez B, Petraco R, Jimenez-Quevedo P, Sen S, Nijjer S, Tarkin J, Alfonso F, Núnez-Gil IJ, Banuelos C, Quirós A, Fernández-Ortiz A, Macaya C, Koo BK, Davies J, Escaned J. Low coronary micro-circulatory resistance associated with profound hypotension during intravenous adenosine infusion: implications for the functional assessment of coronary stenoses. Circ Cardiovasc Interv 2014;7:35-42.
22. Berry C, van't Veer M, Witt N, Kala P, Bocek O, Pyxaras SA, McClure JD, Fearon WF, Barbato E, Tonino PA, De Bruyne B, Pijls NH, Oldroyd KG. VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients. J Am Coll Cardiol 2013;61:1421-1427.
23. Lim WH, Koo BK, Nam CW, Doh JH, Park JJ, Yang HM, Park KW, Kim HS, Takashima H, Waseda K, Amano T, Kato D, Kurita A, Oi M, Toyofuku M, van Nunen L, Pijls NH. Variability of fractional flow reserve according to the methods of hyperemia induction. Catheter Cardiovasc Interv 2014, doi:10.1002/ccd.25752.
24. van Nunen LX, Lenders GD, Schampaert S, van't Veer M, Wijnbergen I, Brueren GR, Tonino PA, Pijls NH. Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement. Euro Intervention 2014, doi:10.4244/EIJY14M08-10.
25. Seto AH, Tehrani DM, Bharmal MI, Kern MJ. Variations of coronary hemodynamic responses to intravenous adenosine infusion: implications for fractional flow reserve measurements. Catheter Cardiovasc Interv 2014;84:416-425.
26. Echavarria-Pinto M, Petraco R, van de Hoef TP, Gonzalo N, Nijjer S, Tarkin JM, Ibanez B, Sen S, Jimenez-Quevedo P, Nunez-Gil IJ, Nombela-Franco L, Alfonso F, Fernández-Ortiz A, Macaya C, Piek JJ, Davies J, Escaned J. Fractional flow reserve and minimum Pd/Pa ratio during intravenous adenosine infusion: very similar but not always the same. EuroIntervention 2014, doi:10.4244/EIJY14M10-09.
27. Matsumoto H, Nakatsuma K, Shimada T, Ushimaru S, Mikuri M, Yamazaki T, Matsuda T. Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement. J Invasive Cardiol 2014;26:580-585.
28. Tarkin JM, Nijjer S, Sen S, Petraco R, Echavarria-Pinto M, Asress KN, Lockie T, Khawaja MZ, Mayet J, Hughes AD, Malik IS, Mikhail GW, Baker CS, Foale RA, Redwood S, Francis DP, Escaned J, Davies JE. Hemodynamic response to intravenous adenosine and its effect on fractional flow reserve assessment: results of the Adenosine for the Functional Evaluation of Coronary Stenosis Severity (AFFECTS) study. Circ Cardiovasc Interv 2013;6:654-661.
29. Adjedj J, Toth GG, Johnson NP, Pellicano M, Ferrara A, Floré V, Gioia GD, Barbato E, Muller O, De Bruyne B. Intracoronary adenosine: dose-response relationship with hyperemia. JACC Cardiovasc Interv 2015; in press.
30. Johnson N, Fearon WF. CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?). https://clinicaltrials.gov/ct2/show/NCT02184117 (15 May 2015).
31. Rudzinski W, Waller AH, Rusovici A, Dehnee A, Nasur A, Benz M, Sanchez S, Klapholz M, Kaluski E. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. Catheter Cardiovasc Interv 2013;81:540-544.
32. Jang HJ, Koo BK, Lee HS, Park JB, Kim JH, Seo MK, Yang HM, Park KW, Nam CW, Doh JH, Kim HS. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J 2013;34:2055-2062.
33. Maartin-Reyes R, de la Torre Hernandez JM, Franco-Pelaez J, Lopez-Palop R, Telleria Arrieta M, Amat Santos IJ, Carrillo Saez P, Sanchez-Recalde A, Sanmartin Pena JC, Garcia Camarero T, Brugaletta S, Gimeno de Carlos F, Pinero A, Sorto Sanchez DC, Frutos A, Lasa Larraya G, Navarro F, Farre J. The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (CAN Intra-Coronary nitroglycerin predict fractional flow reserve without Adenosine?). Catheter Cardiovasc Interv 2015; DOI: 10.1002/ccd.25983.
34. Waksman R, Legutko J, Singh J, Orlando Q, Marso S, Schloss T, Tugaoen J, DeVries J, Palmer N, Haude M, Swymelar S, Torguson R. FIRST: fractional flow reserve and intravascular ultrasound relationship study. J Am Coll Cardiol 2013;61:917-923.
35. Iguchi T, Hasegawa T, Nishimura S, Nakata S, Kataoka T, Ehara S, Hanatani A, Shimada K, Yoshiyama M. Impact of lesion length on functional significance in intermediate coronary lesions. Clin Cardiol 2013;36:172-177.
36. López-Palop R, Carrillo P, Cordero A, Frutos A, Mateo I, Mashlab S, Roldán J. Effect of lesion length on functional significance of intermediate long coronary lesions. Catheter Cardiovasc Interv 2013;81:E186-E194.
37. Takashima H, Waseda K, Gosho M, Kurita A, Ando H, Sakurai S, Maeda K, Kumagai S, Suzuki A, Amano T. Severity of morphological lesion complexity affects fractional flow reserve in intermediate coronary stenosis. J Cardiol 2014, doi: 10.1016/j.jjcc.2014.11.004.
38. Cho HO, Nam CW, Cho YK, Yoon HJ, Park HS, Kim H, Chung IS, Doh JH, Koo BK, Hyun DW, Hur SH, Kim YN, Kim KB. Characteristics of function-anatomy mismatch in patients with coronary artery disease. Korean Circ J 2014;44:394-399.
39. Leone AM, De Caterina AR, Basile E, Gardi A, Laezza D, Mazzari MA, Mongiardo R, Kharbanda R, Cuculi F, Porto I, Niccoli G, Burzotta F, Trani C, Banning AP, Rebuzzi AG, Crea F. Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve. Circ Cardiovasc Interv 2013;6:29-36.
40. Lim HS, Tonino PA, De Bruyne B, Yong AS, Lee BK, Pijls NH, Fearon WF. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. Int J Cardiol 2014;177:66-70.
41. Kang SJ, Ahn JM, Han S, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Mintz GS, Park SJ. Sex differences in the visual-functional mismatch between coronary angiography or intravascular ultrasound versus fractional flow reserve. JACC Cardiovasc Interv 2013;6:562-568.
42. Li J, Rihal CS, Matsuo Y, Elrashidi MY, Flammer AJ, Lee MS, Cassar A, Lennon RJ, Herrmann J, Bell MR, Holmes DR, Bresnahan JF, Hua Q, Lerman LO, Lerman A. Sex-related differences in fractional flow reserve-guided treatment. Circ Cardiovasc Interv 2013;6:662-670.
43. Fearon WF, Aarnoudse W, Pijls NH, De Bruyne B, Balsam LB, Cooke DT, Robbins RC, Fitzgerald PJ, Yeung AC, Yock PG. Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation 2004;109:2269-2272.
44. Yong AS, Layland J, Fearon WF, Ho M, Shah MG, Daniels D, Whitbourn R, Macisaac A, Kritharides L, Wilson A, Ng MK. Calculation of the index of microcir-culatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC Cardiovasc Interv 2013;6:53-58.
45. Murai T, Lee T, Yonetsu T, Iwai T, Takagi T, Hishikari K, Masuda R, Iesaka Y, Isobe M, Kakuta T. Variability of microcirculatory resistance index and its relationship with fractional flow reserve in patients with intermediate coronary artery lesions. Circ J 2013;77:1769-1776.
46. Kobayashi Y, Fearon WF. Invasive coronary microcirculation assessment-current status of index of microcirculatory resistance. Circ J 2014;78:1021-1028.
47. Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R, Camici PG, Cerqueira MD, Chow BJ, Di Carli MF, Dorbala S, Gewirtz H, Gropler RJ, Kaufmann PA, Knaapen P, Knuuti J, Merhige ME, Rentrop KP, Ruddy TD, Schelbert HR, Schindler TH, Schwaiger M, Sdringola S, Vitarello J, Williams KA Sr, Gordon D, Dilsizian V, Narula J. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 2013;62:1639-1653.
48. Echavarŕia-Pinto M, van de Hoef TP, Serruys PW, Piek JJ, Escaned J. Facing the complexity of ischaemic heart disease with intracoronary pressure and flow measurements: beyond fractional flow reserve interrogation of the coronary circulation. Curr Opin Cardiol 2014;29:564-570.
49. Echavarria-Pinto M, Escaned J, Maćias E, Medina M, Gonzalo N, Petraco R, Sen S, Jimenez-Quevedo P, Hernandez R, Mila R, Ibanez B, Nunez-Gil IJ, Fernández C, Alfonso F, Banuelos C, Garćia E, Davies J, Fernández-Ortiz A, Macaya C. Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation 2013;128:2557-2566.
50. Lee BK, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, Lee DP, Yeung AC, Tremmel JA. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation 2015;131:1054-1060.
51. van de Hoef TP, van Lavieren MA, Damman P, Delewi R, Piek MA, Chamuleau SA, Voskuil M, Henriques JP, Koch KT, de Winter RJ, Spaan JA, Siebes M, Tijssen JG, Meuwissen M, Piek JJ. Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circ Cardiovasc Interv 2014;7:301-311.
52. Johnson et al. The distal evaluation of functional performance with intravascular sensors to assess the narrowing effect-combined pressure and Doppler FLOW Velocity Measurements (DEFINE-FLOW). https://clinicaltrials.gov/ct2/show/NCT02328820 (15 May 2015).
53. Meuwissen M, Siebes M, Chamuleau SA, van Eck-Smit BL, Koch KT, de Winter RJ, Tijssen JG, Spaan JA, Piek JJ. Hyperemic stenosis resistance index for evaluation of functional coronary lesion severity. Circulation 2002;106:441-446.
54. van de Hoef TP, Nolte F, EchavarrIa-Pinto M, van Lavieren MA, Damman P, Chamuleau SA, Voskuil M, Verberne HJ, Henriques JP, van Eck-Smit BL, Koch KT, de Winter RJ, Spaan JA, Siebes M, Tijssen JG, Meuwissen M, Piek JJ. Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment. Heart 2014;100:951-959.
55. Barbato E, Aarnoudse W, Aengevaeren WR, Werner G, Klauss V, Bojara W, Herzfeld I, Oldroyd KG, Pijls NH, De Bruyne B; Week 25 study group. Validation of coronary flow reserve measurements by thermodilution in clinical practice. Eur Heart J 2004;25:219-223.
56. Leone AM, Scalone G, De Maria GL, Tagliaferro F, Gardi A, Clemente F, Basile E, Cialdella P, De Caterina AR, Porto I, Aurigemma C, Burzotta F, Niccoli G, Trani C, Rebuzzi AG, Crea F. Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study. EuroIntervention 2014, doi: 10.4244/EIJY14M07-02.
57. Johnson NP, Johnson DT, Kirkeeide RL, Berry C, De Bruyne B, Fearon WF, Oldroyd KG, Pijls NJH, Gould KL. Repeatability of fractional flow reserve (FFR) despite variations in systemic and coronary hemodynamics. J Am Coll Cardiol Intv 2015;8: in press.
58. Abe M, Tomiyama H, Yoshida H, Doba N. Diastolic fractional flow reserve to assess the functional severity of moderate coronary artery stenoses. Circulation 2000; 102:2365-2370.
59. Chalyan DA, Zhang Z, Takarada S, Molloi S. End-diastolic fractional flow reserve: comparison with conventional full-cardiac cycle fractional flow reserve. Circ Cardi-ovasc Interv 2014;7:28-34.
60. Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, Dunning A, DeFrance T, Lansky A, Leipsic J, Min JK. Diagnosis of ischemia-causing coronary stenoses by non-invasive fractional flow reserve computed from coronary computed tomographic angiograms. J Am Coll Cardiol 2011;58:1989-1997.
61. Nørgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, Jensen JM, Mauri L, De Bruyne B, Bezerra H, Osawa K, Marwan M, Naber C, Erglis A, Park SJ, Christiansen EH, Kaltoft A, Lassen JF, Bøtker HE, Achenbach S; NXT Trial Study Group. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease. J Am Coll Cardiol 2014;63:1145-1155.
62. Tu S, Barbato E, Köszegi Z, Yang J, Sun Z, Holm NR, Tar B, Li Y, Rusinaru D, Wijns W, Reiber JHC. Fractional flow reserve calculation from 3-dimensional quantitative coronary angiography and TIMI frame count: a fast computer model to quantify the functional significance of moderately obstructed coronary arteries. JACC Cardiovasc Interv 2014;7:768-777.
63. Morris PD, Ryan D, Morton AC, Lycett R, Lawford PV, Hose DR, Gunn JP. Virtual fractional flow reserve from coronary angiography: modeling the significance of coronary lesions: results from the VIRTU-1 (VIRTUal Fractional Flow Reserve From Coronary Angiography) study. JACC Cardiovasc Interv 2013;6:149-157.
64. Mamas MA, Horner S, Welch E, Ashworth A, Millington S, Fraser D, Fath-Ordoubadi F, Neyses L, El-Omar M. Resting Pd/Pa measured with intracoron-ary pressure wire strongly predicts fractional flow reserve. J Invasive Cardiol 2010; 22:260-265.
65. Kwon T-G, Matsuzawa Y, Li J, Aoki T, Guddeti RR, Widmer RJ, Cilluffo RR, Lennon RJ, Lerman LO, Lerman A. Clinical usefulness of nonhyperemic baseline Pd/Pa as a hybrid baseline Pd/Pa-fractional flow reserve strategy. Coron Artery Dis 2015;26:49-55.
66. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, Tarkin J, Petraco R, Broyd C, Jabbour R, Sethi A, Baker CS, Bellamy M, Al-Bustami M, Hackett D, Khan M, Lefroy D, Parker KH, Hughes AD, Francis DP, Di Mario C, Mayet J, Davies JE. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol 2012;59:1392-1402.
67. Petraco R, Escaned J, Sen S, Nijjer S, Asrress KN, Echavarria-Pinto M, Lockie T, Khawaja MZ, Cuevas C, Foin N, Broyd C, Foale RA, Hadjiloizou N, Malik IS, Mikhail GW, Sethi A, Kaprielian R, Baker CS, Lefroy D, Bellamy M, Al-Bustami M, Khan MA, Hughes AD, Francis DP, Mayet J, Di Mario C, Redwood S, Davies JE. Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry. EuroIntervention 2013;9:91-101.
68. Petraco R, Park JJ, Sen S, Nijjer SS, Malik IS, Echavarŕia-Pinto M, Asrress KN, Nam CW, Maćias E, Foale RA, Sethi A, Mikhail GW, Kaprielian R, Baker CS, Lefroy D, Bellamy M, Al-Bustami M, Khan MA, Gonzalo N, Hughes AD, Francis DP, Mayet J, Di Mario C, Redwood S, Escaned J, Koo BK, Davies JE. Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation. EuroIntervention 2013;8:1157-1165.
69. Jeremias A, Maehara A, Généreux P, Asrress KN, Berry C, De Bruyne B, Davies JE, Escaned J, Fearon WF, Gould KL, Johnson NP, Kirtane AJ, Koo B-K, Marques KM, Nijjer S, Oldroyd KG, Petraco R, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JAE, Van't Veer M, Mintz GS, Stone GW. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol 2014;63:1253-1261.
70. Johnson NP, Kirkeeide RL, Asrress KN, Fearon WF, Lockie T, Marques KMJ, Pyxaras SA, Rolandi MC, van't Veer M, De Bruyne B, Piek JJ, Pijls NHJ, Redwood S, Siebes M, Spaan JAE, Gould KL. Does the instantaneous wave-free ratio approximate the fractional flow reserve? J Am Coll Cardiol 2013;61: 1428-1435.
71. Sen S, Asrress KN, Nijjer S, Petraco R, Malik IS, Foale RA, Mikhail GW, Foin N, Broyd C, Hadjiloizou N, Sethi A, Al-Bustami M, Hackett D, Khan MA, Khawaja MZ, Baker CS, Bellamy M, Parker KH, Hughes AD, Francis DP, Mayet J, Di Mario C, Escaned J, Redwood S, Davies JE. Diagnostic classification of the instantaneous wave-free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration. Results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study). J Am Coll Car-diol 2013;61:1409-1420.
72. Petraco R, Al-Lamee R, Gotberg M, Sharp A, Hellig F, Nijjer SS, Echavarria-Pinto M, van de Hoef TP, Sen S, Tanaka N, Van Belle E, Bojara W, Sakoda K, Mates M, Indolfi C, De Rosa S, Vrints CJ, Haine S, Yokoi H, Ribichini FL, Meuwissen M, Matsuo H, Janssens L, Katsumi U, Di Mario C, Escaned J, Piek J, Davies JE. Real-time use of instantaneous wave-free ratio: Results of the ADVISE in-practice: An international, multicenter evaluation of instantaneous wave-free ratio in clinical practice. Am Heart J 2014;168:739-748.
73. Petraco R, van de Hoef TP, Nijjer S, Sen S, van Lavieren MA, Foale RA, Meuwissen M, Broyd C, Echavarria-Pinto M, Foin N, Malik IS, Mikhail GW, Hughes AD, Francis DP, Mayet J, Di Mario C, Escaned J, Piek JJ, Davies JE. Baseline instantaneous wave-free ratio as a pressure-only estimation of underlying coronary flow reserve: results of the JUSTIFY-CFR Study (Joined Coronary Pressure and Flow Analysis to Determine Diagnostic Characteristics of Basal and Hyperemic Indices of Functional Lesion Severity-Coronary Flow Reserve). Circ Cardiovasc Interv 2014;7:492-502.
74. Davies JER, Sen S. Prospective, multi-center, double blind, randomised study to test the safety of deferral of stenting in physiological non-significant lesions in a clinical population of intermediate stenoses using iFR and FFR (DEFINE-FLAIR). https://clinicaltrials.gov/ct2/show/NCT02053038 (15 May 2015).
75. Götberg M, Jacobsson E. Instantaneous wave-free ratio versus fractional flow reserve in patients with stable angina pectoris or acute coronary syndrome. A multi-center, prospective, randomized controlled clinical trial based on the Swedish Angiography and Angioplasty Registry (SWEDEHEART) platform. https://clinicaltrials.gov/ct2/show/NCT02166736 (15 May 2015).
76. Park SJ, Ahn JM, Park GM, Cho YR, Lee JY, Kim WJ, Han S, Kang SJ, Park DW, Lee SW, Kim YH, Lee CW, Mintz GS, Park SW. Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice. Eur Heart J 2013;34:3353-3361.
77. Frohlich GM, Redwood S, Rakhit R, MacCarthy PA, Lim P, Crake T, White SK, Knight CJ, Kustosz C, Knapp G, Dalby MC, Mali IS, Archbold A, Wragg A, Timmis AD, Meier P. Long-term survival in patients undergoing percutaneous interventions with or without intracoronary pressure wire guidance or intracoronary ultrasonographic imaging: a large cohort study. JAMA Intern Med 2014;174:1360-1366.
78. Li J, Elrashidi MY, Flammer AJ, Lennon RJ, Bell MR, Holmes DR, Bresnahan JF, Rihal CS, Lerman LO, Lerman A. Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J 2013;34:1375-1383.
79. Di Serafino L, De Bruyne B, Mangiacapra F, Bartunek J, Agostoni P, Vanderheyden M, Scognamiglio G, Heyndrickx GR, Wijns W, Barbato E. Long-term clinical outcome after fractional flow reserve-versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts. Am Heart J 2013;166:110-118.
80. Depta JP, Patel JS, Novak E, Masrani SK, Raymer D, Facey G, Patel Y, Zajarias A, Lasala JM, Singh J, Bach RG, Kurz HI. Outcomes of coronary stenoses deferred re-vascularization for borderline versus nonborderline fractional flow reserve values. Am J Cardiol 2014;113:1788-1793.
81. Depta JP, Patel JS, Novak E, Gage BF, Masrani SK, Raymer D, Facey G, Patel Y, Zajarias A, Lasala JM, Amin AP, Kurz HI, Singh J, Bach RG. Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment. Eur Heart J 2015;36:509-515.
82. Curzen N, Rana O, Nicholas Z, Golledge P, Zaman A, Oldroyd K, Hanratty C, Banning A, Wheatcroft S, Hobson A, Chitkara K, Hildick-Smith D, McKenzie D, Calver A, Dimitrov BD, Corbett S. Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?: the RIPCORD study. Circ Cardiovasc Interv 2014;7:248-255.
83. Van Belle E, Rioufol G, Pouillot C, Cuisset T, Bougrini K, Teiger E, Champagne S, Belle L, Barreau D, Hanssen M, Besnard C, Dauphin R, Dallongeville J, El Hahi Y, Sideris G, Bretelle C, Lhoest N, Barnay P, Leborgne L, Dupouy P; Investigators of the Registre Français de la FFR-R3F. Outcome impact of coronary revascular-ization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation 2014;129:173-185.
84. Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, Agostoni P, Appelman Y, Arslan F, Barbato E, Chen SL, Di Serafino L, Domínguez-Franco AJ, Dupouy P, Esen AM, Esen OB, Hamilos M, Iwasaki K, Jensen LO, Jiménez-Navarro MF, Katritsis DG, Kocaman SA, Koo BK, López-Palop R, Lorin JD, Miller LH, Muller O, Nam CW, Oud N, Puymirat E, Rieber J, Rioufol G, Rodés-Cabau J, Sedlis SP, Takeishi Y, Tonino PA, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NH, De Bruyne B, Gould KL. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 2014;64:1641-1654.
85. Hochman JS, Maron DJ. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial. https://clinicaltrials. gov/ct2/show/NCT01471522 (15 May 2015).
86. Cuculi F, De Maria GL, Meier P, Dall'Armellina E, de Caterina AR, Channon KM, Prendergast BD, Choudhury RC, Forfar JC, Kharbanda RK, Banning AP. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014;64:1894-1904.
87. Berry C, Layland J, Sood A, Curzen NP, Balachandran KP, Das R, Junejo S, Henderson RA, Briggs AH, Ford I, Oldroyd KG. Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial. Am Heart J 2013;166:662-668.e3.
88. Layland J, Oldroyd KG, Curzen N, Sood A, Balachandran K, Das R, Junejo S, Ahmed N, Lee MM, Shaukat A, O'Donnell A, Nam J, Briggs A, Henderson R, McConnachie A, Berry C; FAMOUS-NSTEMI investigators. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J 2015;36:100-111.
89. Layland J, Rauhalammi S, Watkins S, Ahmed N, McClure J, Carrick D, O'Donnell A, Sood A, Petrie MC, Vanessa TYM, Eteiba H, Lindsay MML, McEntegart M, Oldroyd KG, Radjenovic A, Berry C. Assessment of fractional flow reserve in patients with recent non-ST segment myocardial infarction: a comparative study with 3 Tesla stress perfusion cardiac magnetic resonance imaging. Circ Cardiovasc Interv 2015; in press.
90. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32: 2999-3054.
91. Task Force on the Management of ST-segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. ESC guidelines for the management of acute myo-cardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
92. Engstrom T. Primary PCI in patients with ST-elevation myocardial infarction and multivessel disease: treatment of culprit lesion only or complete revascularization. A randomised comparison of the clinical outcome after complete revascularisation versus treatment of the infarct-related artery only during primary percutaneous coronary intervention. https://clinicaltrials.gov/ct2/show/NCT01960933.
93. Smits P. Fractional flow reserve guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease. https://clinicaltrials.gov/ct2/show/NCT01399736.
94. Mehta S. Randomized comparative effectiveness study of complete vs culprit-only revascularization strategies to treat multi-vessel disease after primary percutaneous coronary intervention (PCI) for ST-segment Elevation Myocardial (STEMI) infarction. https://clinicaltrials.gov/ct2/show/NCT01740479.
95. Ripley DP, Brown JM, Everett CC, Bijsterveld P, Walker S, Sculpher M, McCann GP, Berry C, Plein S, Greenwood JP. Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): a prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease. Am Heart J 2015;169:17-24.